ANDA 89003, held by Fresenius Kabi USA. Phenytoin Sodium.
As of Nov 16, 2026, ANDA 89003 (Phenytoin Sodium), held by Fresenius Kabi USA, was first approved by FDA on May 31, 1985, with 5 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 31, 1985 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Phenytoin Sodium50MG/ML ยท injectable;injection | Phenytoin Sodium | Discontinued |
| Mar 8, 1995 | Supplement 7Manufacturing | Approved | None posted |
| Jan 26, 1995 | Supplement 4Manufacturing | Approved | None posted |
| Jan 14, 1993 | Supplement 6Labeling | Approved | None posted |
| Aug 20, 1991 | Supplement 5Labeling | Approved | None posted |
| Feb 4, 1991 | Supplement 2Labeling | Approved | None posted |
| May 31, 1985 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters